Stevens Capital Management LP Acquires Shares of 14,495 Masimo Corporation (MASI)

Stevens Capital Management LP acquired a new position in Masimo Corporation (NASDAQ:MASI) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 14,495 shares of the medical equipment provider’s stock, valued at approximately $1,255,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Fortaleza Asset Management Inc. bought a new stake in shares of Masimo Corporation during the second quarter valued at approximately $106,000. Dubuque Bank & Trust Co. raised its stake in shares of Masimo Corporation by 3.4% during the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after acquiring an additional 61 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Masimo Corporation by 13.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock valued at $184,000 after acquiring an additional 236 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in shares of Masimo Corporation during the second quarter valued at approximately $203,000. Finally, Advisor Group Inc. raised its stake in shares of Masimo Corporation by 38.4% during the second quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock valued at $216,000 after acquiring an additional 655 shares in the last quarter. 84.94% of the stock is owned by institutional investors and hedge funds.

Masimo Corporation (NASDAQ MASI) opened at $85.68 on Tuesday. The stock has a market cap of $4,469.04, a P/E ratio of 33.14, a P/E/G ratio of 2.91 and a beta of 0.75. Masimo Corporation has a 1-year low of $60.03 and a 1-year high of $104.71.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.17. The company had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. Masimo Corporation’s revenue was up 15.6% compared to the same quarter last year. During the same period last year, the company posted $0.52 earnings per share. analysts anticipate that Masimo Corporation will post 2.96 EPS for the current fiscal year.

In other Masimo Corporation news, Director Sanford Fitch sold 11,000 shares of Masimo Corporation stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the transaction, the director now directly owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Yongsam Lee sold 13,976 shares of Masimo Corporation stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the completion of the transaction, the executive vice president now directly owns 74,000 shares in the company, valued at $6,617,820. The disclosure for this sale can be found here. Insiders sold 39,976 shares of company stock worth $3,559,074 over the last ninety days. Corporate insiders own 13.10% of the company’s stock.

Several research firms have recently weighed in on MASI. BidaskClub downgraded shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Monday, August 14th. Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price target on shares of Masimo Corporation in a research note on Friday, November 3rd. Zacks Investment Research raised shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a report on Thursday, November 2nd. Finally, Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $97.17.

TRADEMARK VIOLATION NOTICE: “Stevens Capital Management LP Acquires Shares of 14,495 Masimo Corporation (MASI)” was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.themarketsdaily.com/2017/11/14/stevens-capital-management-lp-acquires-shares-of-14495-masimo-corporation-masi.html.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply